✦ LIBER ✦
Randomized, Double-Blind, Placebo-Controlled, Phase III Cross-Over Study Evaluating the Oral Neurokinin-1 Antagonist Aprepitant in Combination With a 5HT3 Receptor Antagonist and Dexamethasone in Patients With Germ Cell Tumors Receiving 5-Day Cisplatin Combination Chemotherapy Regimens: A Hoosier Oncology Group Study
✍ Scribed by Albany, C.; Brames, M. J.; Fausel, C.; Johnson, C. S.; Picus, J.; Einhorn, L. H.
- Book ID
- 115438918
- Publisher
- American Society of Clinical Oncology
- Year
- 2012
- Tongue
- English
- Weight
- 156 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0732-183X
No coin nor oath required. For personal study only.